In the current study, where we focused our investigation on the CD8+ T cell subset, we found no difference in p21 expression, but reduced p16 expression in PD patients versus controls, providing further evidence of an attenuation of CD8+ T cell senescence in PD. Here, CDKN2A is linked to Parkinson disease.